Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas

Shira Varon, Ram Parvataneni, L Elaine Waetjen, Kathleen Dunn, Vanessa L. Jacoby

Research output: Contribution to journalArticle

Abstract

Minimally invasive therapies to treat symptoms of uterine myomas can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization, magnetic resonance–guided focused ultrasound, and laparoscopic radiofrequency ablation, known as the Acessa procedure. Acessa is used to treat women with symptomatic myomas and was approved by the US Food and Drug Administration in 2012. This case describes a patient who underwent Acessa and subsequently required hysterectomy for refractory symptoms. Pathology of her tumor was initially classified as epithelioid leiomyosarcoma but on subsequent review was classified as benign. This report highlights the challenges of accurate histologic diagnosis in the setting of using new therapeutic modalities. Clinicians should report such interventions to pathologists at the time of surgery to allow for accurate diagnosis.

Original languageEnglish (US)
JournalJournal of Minimally Invasive Gynecology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Myoma
Leiomyosarcoma
Diagnostic Errors
Uterine Artery Embolization
United States Food and Drug Administration
Hysterectomy
Pathology
Therapeutics
Neoplasms
Pathologists

Keywords

  • Acessa
  • Leiomyosarcoma
  • Myomas
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas. / Varon, Shira; Parvataneni, Ram; Waetjen, L Elaine; Dunn, Kathleen; Jacoby, Vanessa L.

In: Journal of Minimally Invasive Gynecology, 01.01.2019.

Research output: Contribution to journalArticle

@article{7634dde9461b4d3b865cc54d26abaab6,
title = "Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas",
abstract = "Minimally invasive therapies to treat symptoms of uterine myomas can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization, magnetic resonance–guided focused ultrasound, and laparoscopic radiofrequency ablation, known as the Acessa procedure. Acessa is used to treat women with symptomatic myomas and was approved by the US Food and Drug Administration in 2012. This case describes a patient who underwent Acessa and subsequently required hysterectomy for refractory symptoms. Pathology of her tumor was initially classified as epithelioid leiomyosarcoma but on subsequent review was classified as benign. This report highlights the challenges of accurate histologic diagnosis in the setting of using new therapeutic modalities. Clinicians should report such interventions to pathologists at the time of surgery to allow for accurate diagnosis.",
keywords = "Acessa, Leiomyosarcoma, Myomas, Radiofrequency ablation",
author = "Shira Varon and Ram Parvataneni and Waetjen, {L Elaine} and Kathleen Dunn and Jacoby, {Vanessa L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jmig.2018.08.004",
language = "English (US)",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",

}

TY - JOUR

T1 - Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas

AU - Varon, Shira

AU - Parvataneni, Ram

AU - Waetjen, L Elaine

AU - Dunn, Kathleen

AU - Jacoby, Vanessa L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Minimally invasive therapies to treat symptoms of uterine myomas can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization, magnetic resonance–guided focused ultrasound, and laparoscopic radiofrequency ablation, known as the Acessa procedure. Acessa is used to treat women with symptomatic myomas and was approved by the US Food and Drug Administration in 2012. This case describes a patient who underwent Acessa and subsequently required hysterectomy for refractory symptoms. Pathology of her tumor was initially classified as epithelioid leiomyosarcoma but on subsequent review was classified as benign. This report highlights the challenges of accurate histologic diagnosis in the setting of using new therapeutic modalities. Clinicians should report such interventions to pathologists at the time of surgery to allow for accurate diagnosis.

AB - Minimally invasive therapies to treat symptoms of uterine myomas can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization, magnetic resonance–guided focused ultrasound, and laparoscopic radiofrequency ablation, known as the Acessa procedure. Acessa is used to treat women with symptomatic myomas and was approved by the US Food and Drug Administration in 2012. This case describes a patient who underwent Acessa and subsequently required hysterectomy for refractory symptoms. Pathology of her tumor was initially classified as epithelioid leiomyosarcoma but on subsequent review was classified as benign. This report highlights the challenges of accurate histologic diagnosis in the setting of using new therapeutic modalities. Clinicians should report such interventions to pathologists at the time of surgery to allow for accurate diagnosis.

KW - Acessa

KW - Leiomyosarcoma

KW - Myomas

KW - Radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=85060859289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060859289&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2018.08.004

DO - 10.1016/j.jmig.2018.08.004

M3 - Article

C2 - 30121386

AN - SCOPUS:85060859289

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

ER -